Italy’s Alfasigma Comes Calling After Intercept’s Cruel Summer

 
• By Alaric DeArment
  
Alfasigma is buying Intercept for $19 per share • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business